Buathongsri v. Zenas BioPharma, Inc. et al
Case Number:
1:25-cv-10988
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
- Citigroup Inc.
- Guggenheim Partners LLC
- Jefferies Financial Group Inc.
- Morgan Stanley
- Zenas BioPharma USA LLC
Sectors & Industries:
-
January 26, 2026
Zenas BioPharma Slams Investor's Revamped Fraud Claim
Zenas BioPharma has asked a Massachusetts federal judge to toss a putative investor class action targeting pre-initial public offering statements about the company's spending, saying it didn't hide that it had ramped up investment in research and development.
-
April 17, 2025
Zenas BioPharma Faces Investor Suit Over Post-IPO Plunge
Autoimmune disease therapeutics company Zenas BioPharma Inc. was hit with a proposed shareholder class action alleging that its registration statement for its September 2024 initial public offering overstated the amount of time that the company could fund its operations using existing cash and expected net proceeds from the offering.